-
Info
-
Comments
Jan. 22 (Bloomberg) -- Allergan agreed to pay $25 per share for MAP Pharmaceuticals in what the companies called a “definitive merger agreement.” Matt Miller reports on Bloomberg Television's "Bloomberg Rewind." (Source: Bloomberg)
Allergan to Buy MAP Pharmaceuticals for $958M
Advertisement
BTV Channel Finder
ZIP is required for U.S. locations
Bloomberg Television in change
Rate this Page